CClinicalTrials.gg
CompletedNCT07131098EEFPUpdated Aug 20, 2025

Early Enteral Feeding and Clinical Outcomes in ICU Patients

An interventional study of Early Enteral Feeding Protocol and Standard Nutritional Care in Critical Illness, Enteral Nutrition and Intensive Care Unit ICU, sponsored by Loai Muawiah Zabin. Completed at 1 site in Palestinian Territories. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-20.

Sponsored by Loai Muawiah Zabin · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Jan 2024, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluated the effectiveness of an early enteral feeding protocol in critically ill adult patients admitted to an Intensive Care Unit (ICU). The intervention involved initiating enteral nutrition within 24-48 hours of ICU admission. Clinical outcomes such as ICU length of stay, ventilator dependency, and selected laboratory values were compared between patients who received early enteral feeding and those who received standard nutritional care. The study was conducted at Jenin Governmental Hospital in Palestine between January and April 2024, with 80 adult participants.

Read the detailed description

This is a retrospectively registered, quasi-experimental study that investigated the clinical impact of implementing an early enteral feeding protocol in a critical care setting. Conducted in Jenin Governmental Hospital, Palestine, the research explored how protocolized early nutritional support affects physiological recovery and ICU-related outcomes in critically ill adult patients.

The study was motivated by the well-established role of early enteral nutrition in maintaining gut integrity, supporting immune function, and reducing complications in ICU patients. Despite international guidelines recommending its use within 24-48 hours of ICU admission, early enteral feeding remains underutilized in many low-resource healthcare settings. Factors contributing to this gap include variability in clinical practice, limited institutional protocols, and staff training constraints.

This investigation was carried out between January and April 2024 and followed rigorous ethical standards, with Institutional Review Board approval from Arab American University (Reference: R-2024/B/85/N). Patients were grouped based on the time period of admission into either a protocol-based early feeding group or a standard care group. Intervention fidelity was maintained through a pre-defined feeding protocol implemented by ICU staff after appropriate orientation and monitoring.

The study contributes to the growing body of evidence supporting structured nutritional protocols in ICUs and highlights the feasibility and benefits of such interventions in middle-income and resource-constrained settings. The data gathered and analyzed provide a foundation for future policy development aimed at standardizing nutritional support for critically ill patients.

02

Conditions studied

  • Critical Illness
  • Enteral Nutrition
  • Intensive Care Unit ICU
  • Nutritional Support
  • Feeding Protocol

Browse trials for

Keywords

  • Early enteral feeding
  • ICU nutrition
  • Critically ill patients
  • Quasi-experimental study
  • Palestine
  • Protocol-based nutrition
  • Clinical outcomes
  • Nutritional therapy
  • Mechanical ventilation
  • Length of ICU stay
  • Glasgow Coma Scale (GCS)
  • Laboratory outcomes
  • Bicarbonate
  • Sodium
  • Platelets
  • Hemoglobin
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 80 is below the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Loai Muawiah Zabin is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 18 years and older
  • Admitted to the ICU and eligible for enteral feeding
  • Expected to stay in the ICU for more than 48 hours
  • Able to initiate enteral feeding within 24-48 hours of ICU admission
  • Informed consent obtained from the patient or legal guardian

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating women
  • Patients with gastrointestinal bleeding or obstruction
  • Patients undergoing gastrointestinal surgery or with short bowel syndrome
  • Diagnosed with COVID-19 during admission
  • End-of-life care patients or those with do-not-resuscitate (DNR) orders
  • Refusal to participate or withdrawal of consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Early Enteral Feeding Protocol

    Participants in this group received early enteral nutrition initiated within 24-48 hours of ICU admission, based on a structured feeding protocol. The protocol followed international guidelines (ASPEN/ESPEN) and was implemented by ICU staff with training and monitoring support.

    Other: Early Enteral Feeding Protocol

  • Other
    Standard Nutritional Care

    Participants in this group received standard ICU nutritional care without the implementation of the early enteral feeding protocol. Feeding initiation and type were left to physician discretion based on clinical judgment and routine hospital practices.

    Other: Standard Nutritional Care

Interventions

  • OtherEarly Enteral Feeding Protocol

    Early enteral nutrition was initiated within 24-48 hours of ICU admission based on a structured protocol aligned with ASPEN and ESPEN guidelines. The protocol defined target caloric goals, methods of tube feeding initiation, rate advancement, and monitoring procedures. Nurses and ICU staff were trained in protocol implementation. The goal was to optimize nutrition early in critical illness to improve clinical outcomes such as ICU length of stay, ventilator dependence, and physiological stability.

  • OtherStandard Nutritional Care

    Patients in the control group received standard nutritional care per routine hospital practices. Initiation and progression of feeding were left to the discretion of the attending physician and nursing staff, without the use of a structured protocol or defined early feeding timeline.

06

What researchers measure

Primary outcomes

  1. Length of ICU Stay (in days)

    Duration of patient stay in the intensive care unit, measured in full days from admission to discharge.

    Time frame: Through ICU discharge, up to 7 days

Secondary outcomes

  1. Glasgow Coma Scale (GCS) Score

    Assessment of neurological status using the GCS; higher scores indicate better consciousness levels.

    Time frame: Daily for up to 7 days.

  2. Hemoglobin Level (g/dL)

    Laboratory measure of hemoglobin concentration as an indicator of oxygen-carrying capacity and blood loss.

    Time frame: Day 1 and Day 7 of ICU stay

  3. Bicarbonate (HCO₃) Level (mEq/L)

    Blood bicarbonate levels used to assess acid-base balance in critically ill patients.

    Time frame: Day 1 and Day 7 of ICU stay

  4. Platelet Count (×10³/μL)

    Platelet concentration is measured from a complete blood count to evaluate clotting potential and bone marrow function.

    Time frame: Day 1 and Day 7 of ICU stay

  5. Calcium Level (mg/dL)

    Measurement of serum calcium levels to assess electrolyte balance and nutritional status.

    Time frame: Day 1 and Day 7 of ICU stay

  6. Mechanical Ventilation Duration (in days)

    Total number of days the patient required mechanical ventilation during ICU stay.

    Time frame: Through ICU discharge, up to 7 days

  7. Fraction of Inspired Oxygen (FiO₂) Requirement (%)

    Daily measurement of the fraction of inspired oxygen (%) required by patients during mechanical ventilation in the ICU, used to assess respiratory support needs. Values will be recorded once daily and analyzed as mean values over the ICU stay.

    Time frame: Daily for up to 7 days

  8. Positive End-Expiratory Pressure (PEEP) Requirement (cmH₂O)

    Daily measurement of positive end-expiratory pressure (PEEP, in cmH₂O) applied during mechanical ventilation in the ICU, used to assess respiratory support needs. Values will be recorded once daily and analyzed as mean values over the ICU stay.

    Time frame: Daily for up to 7 days

07

Study locations

1 site
  • Jenin Governmental Hospital
    Jenin, 00970, Palestinian Territories
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) collected during this study will not be shared publicly due to ethical and legal restrictions. The study involved critically ill patients in an intensive care setting, and data sharing was not included in the original informed consent or ethics approval. Ensuring patient confidentiality and privacy remains a top priority.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07131098
Lead sponsor
Loai Muawiah Zabin
Responsible party
Loai Muawiah Zabin (Faculty Member, Arab American University, Arab American University (Palestine)) — Sponsor-investigator
First posted
Aug 20, 2025
Start date
Jan 1, 2024
Primary completion
Apr 30, 2024
Completion
Apr 30, 2024
Last update
Aug 20, 2025

Study contacts

Hussein Mahameed, Master
principal investigator · Arab American University (Palestine)
Sajed Ghawadra, PhD
study chair · Arab American University (Palestine)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion